CNSP
CNS Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
CNSP fundamentals
CNS Pharmaceuticals (CNSP) released its earnings on Aug 14, 2025: revenue was -- (YoY --), beat estimates; EPS was -6.42 (YoY +99.84%), beat estimates.
Revenue / YoY
--
--
EPS / YoY
-6.42
+99.84%
Report date
Aug 14, 2025
EPS
Actual | -108000 | -135000 | -126000 | -81000 | -111300 | -77700 | -32400 | -4032 | -150 | -447.96 | -18.96 | -6.42 | ||||
Forecast | -108000 | -117000 | -120000 | -144000 | -54000 | -72000 | -51900 | -57000 | -60 | -87.96 | -24 | -9.6 | ||||
Surprise | 0.00% | 0.00% | -15.38% | -5.00% | 0.00% | -50.00% | -54.58% | 0.00% | +37.57% | 0.00% | 0.00% | 0.00% | -150.00% | -409.28% | +21.00% | +33.13% |
Revenue
Actual | -- | 0 | 0 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Forecast | -- | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is CNS Pharmaceuticals's gross profit margin?Did CNS Pharmaceuticals beat or miss consensus estimates last quarter?What is the market's earnings forecast for CNS Pharmaceuticals next quarter?What is the revenue and EPS growth rate for CNS Pharmaceuticals year over year?What factors drove the changes in CNS Pharmaceuticals's revenue and profit?What were the key takeaways from CNS Pharmaceuticals’s earnings call?What guidance did CNS Pharmaceuticals's management provide for the next earnings period?What does CNS Pharmaceuticals do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
